Literature DB >> 10023610

Cocaine abstinence symptomatology and treatment attrition.

F D Mulvaney1, A I Alterman, C R Boardman, K Kampman.   

Abstract

Premature termination from outpatient cocaine treatment predicts a number of poor outcomes, including higher rates of relapse and unemployment. This study attempted to predict dropouts from outpatient cocaine treatment, as well as those unable to achieve initial abstinence from cocaine, using two baseline variables that had previously been shown to predict treatment dropout: a measure of the severity of cocaine abstinence symptomatology using the Cocaine Selective Severity Assessment (CSSA) and the initial urine toxicology. Results of logistic regression analyses indicated that those with more intense abstinence symptoms, as measured by the CSSA, were five times more likely to terminate treatment prematurely. When combined with the CSSA, the initial urine did not significantly predict dropouts. The CSSA and the baseline urine were equal in their ability to predict those who would fail in their initial attempts to achieve abstinence. Implications for treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023610     DOI: 10.1016/s0740-5472(98)00017-8

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  28 in total

1.  When should we delay highly active antiretroviral therapy?

Authors:  D R Bangsberg; A Moss
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

Review 2.  Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Authors:  Kathleen M Carroll; Thomas R Kosten; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

Review 3.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 4.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

Review 5.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 6.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

Review 7.  Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Authors:  Sara K Blaine; Rajita Sinha
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

8.  Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.

Authors:  Annie Umbricht; Anthony DeFulio; Erin L Winstanley; D Andrew Tompkins; Jessica Peirce; Miriam Z Mintzer; Eric C Strain; George E Bigelow
Journal:  Drug Alcohol Depend       Date:  2014-04-16       Impact factor: 4.492

Review 9.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.

Authors:  Jamshid Ahmadi; Kyle M Kampman; David M Oslin; Helen M Pettinati; Charles Dackis; Thorne Sparkman
Journal:  Am J Addict       Date:  2009 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.